Russell Investments Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.21M | Buy |
92,392
+1,366
| +2% | +$32.6K | ﹤0.01% | 1674 |
|
2025
Q1 | $2.26M | Buy |
91,026
+43,863
| +93% | +$1.09M | ﹤0.01% | 1622 |
|
2024
Q4 | $889K | Buy |
47,163
+46,179
| +4,693% | +$870K | ﹤0.01% | 2060 |
|
2024
Q3 | $14.8K | Sell |
984
-54,511
| -98% | -$820K | ﹤0.01% | 3018 |
|
2024
Q2 | $1.59M | Sell |
55,495
-4,537
| -8% | -$130K | ﹤0.01% | 1756 |
|
2024
Q1 | $1.75M | Sell |
60,032
-166,241
| -73% | -$4.86M | ﹤0.01% | 1713 |
|
2023
Q4 | $7.63M | Sell |
226,273
-123,756
| -35% | -$4.18M | 0.01% | 922 |
|
2023
Q3 | $10.7M | Buy |
350,029
+155,394
| +80% | +$4.77M | 0.02% | 726 |
|
2023
Q2 | $7.8M | Sell |
194,635
-109,152
| -36% | -$4.37M | 0.02% | 893 |
|
2023
Q1 | $12.4M | Sell |
303,787
-27,077
| -8% | -$1.11M | 0.02% | 686 |
|
2022
Q4 | $12.8M | Sell |
330,864
-163,864
| -33% | -$6.33M | 0.03% | 677 |
|
2022
Q3 | $26.3M | Buy |
494,728
+38,888
| +9% | +$2.07M | 0.06% | 399 |
|
2022
Q2 | $26.6M | Buy |
455,840
+162,736
| +56% | +$9.49M | 0.05% | 415 |
|
2022
Q1 | $22.4M | Buy |
293,104
+161,757
| +123% | +$12.3M | 0.04% | 524 |
|
2021
Q4 | $7.9M | Buy |
131,347
+127,924
| +3,737% | +$7.7M | 0.01% | 1023 |
|
2021
Q3 | $191K | Buy |
3,423
+975
| +40% | +$54.4K | ﹤0.01% | 2783 |
|
2021
Q2 | $148K | Hold |
2,448
| – | – | ﹤0.01% | 2988 |
|
2021
Q1 | $171K | Buy |
+2,448
| New | +$171K | ﹤0.01% | 2868 |
|
2020
Q4 | – | Sell |
-3,828
| Closed | -$230K | – | 3153 |
|
2020
Q3 | $230K | Sell |
3,828
-64,393
| -94% | -$3.87M | ﹤0.01% | 2723 |
|
2020
Q2 | $3.58M | Buy |
68,221
+284
| +0.4% | +$14.9K | 0.01% | 1299 |
|
2020
Q1 | $2.28M | Buy |
67,937
+54,140
| +392% | +$1.81M | 0.01% | 1397 |
|
2019
Q4 | $623K | Buy |
13,797
+2,936
| +27% | +$133K | ﹤0.01% | 2311 |
|
2019
Q3 | $414K | Sell |
10,861
-11,055
| -50% | -$421K | ﹤0.01% | 2369 |
|
2019
Q2 | $953K | Sell |
21,916
-78,442
| -78% | -$3.41M | ﹤0.01% | 2008 |
|
2019
Q1 | $3.82M | Sell |
100,358
-51,518
| -34% | -$1.96M | 0.01% | 1384 |
|
2018
Q4 | $6.53M | Buy |
151,876
+91,161
| +150% | +$3.92M | 0.01% | 1013 |
|
2018
Q3 | $2.97M | Buy |
60,715
+4,105
| +7% | +$201K | 0.01% | 1550 |
|
2018
Q2 | $1.81M | Buy |
56,610
+7,249
| +15% | +$232K | ﹤0.01% | 1811 |
|
2018
Q1 | $1.54M | Buy |
49,361
+19,031
| +63% | +$593K | ﹤0.01% | 1995 |
|
2017
Q4 | $1.38M | Buy |
30,330
+5,273
| +21% | +$240K | ﹤0.01% | 1991 |
|
2017
Q3 | $940K | Sell |
25,057
-258,456
| -91% | -$9.7M | ﹤0.01% | 2171 |
|
2017
Q2 | $13.5M | Buy |
283,513
+275,850
| +3,600% | +$13.2M | 0.02% | 768 |
|
2017
Q1 | $349K | Sell |
7,663
-504
| -6% | -$23K | ﹤0.01% | 2553 |
|
2016
Q4 | $256K | Buy |
+8,167
| New | +$256K | ﹤0.01% | 2661 |
|